Cargando…
Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD Mice
OBJECTIVE: Interleukin (IL)-21 is a type 1 cytokine that has been implicated in the pathogenesis of type 1 diabetes via the unique biology of the nonobese diabetic (NOD) mouse strain. The aim of this study was to investigate a causal role for IL-21 in type 1 diabetes. RESEARCH DESIGN AND METHODS: We...
Autores principales: | Sutherland, Andrew P.R., Van Belle, Tom, Wurster, Andrea L., Suto, Akira, Michaud, Monia, Zhang, Dorothy, Grusby, Michael J., von Herrath, Matthias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671036/ https://www.ncbi.nlm.nih.gov/pubmed/19208913 http://dx.doi.org/10.2337/db08-0882 |
Ejemplares similares
-
Interleukin 21 Is a T Helper (Th) Cell 2 Cytokine that Specifically Inhibits the Differentiation of Naive Th Cells into Interferon γ–producing Th1 Cells
por: Wurster, Andrea L., et al.
Publicado: (2002) -
Development and characterization of IL-21–producing CD4(+) T cells
por: Suto, Akira, et al.
Publicado: (2008) -
Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNγ
por: Fousteri, G., et al.
Publicado: (2010) -
Following the Fate of One Insulin-Reactive CD4 T cell: Conversion Into Teffs and Tregs in the Periphery Controls Diabetes in NOD Mice
por: Fousteri, Georgia, et al.
Publicado: (2012) -
NK Cells Are Not Required for Spontaneous Autoimmune Diabetes in NOD Mice
por: Beilke, Joshua N., et al.
Publicado: (2012)